268 filings
Page 4 of 14
8-K
caqp6h1hz uub
27 Feb 20
Denali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights
5:17pm
SC 13G/A
2x5sbjfh xru
13 Feb 20
Denali Therapeutics Inc.
4:52pm
SC 13G/A
rglhy3d2
13 Feb 20
Beneficial ownership report (amended)
4:18pm
4
xij0xu ljf
12 Feb 20
Denali Therapeutics / Alexander O. Schuth ownership change
6:03pm
4
zcgrwm ys
12 Feb 20
Denali Therapeutics / Steve E. Krognes ownership change
6:03pm
4
mbsp0
12 Feb 20
Denali Therapeutics / Ryan J. Watts ownership change
6:02pm
4
x5jahc7bh0xjsaeo g0s
12 Feb 20
Denali Therapeutics / Carole Ho ownership change
6:01pm
SC 13G/A
zno2xj pi54
12 Feb 20
Beneficial ownership report (amended)
11:13am
SC 13G/A
iq44989
11 Feb 20
Beneficial ownership report (amended)
4:00pm
SC 13G/A
qg77wozagu
10 Feb 20
Beneficial ownership report (amended)
2:19pm
SC 13G/A
p55l6up ple0r409
7 Feb 20
Denali Therapeutics Inc.
11:18am
SC 13G
h7al6dfc
7 Feb 20
Beneficial ownership report
8:45am
8-K
wrsygmss5p r9ccu
29 Jan 20
Denali Therapeutics Announces Pricing of Public Offering of Common Stock
4:25pm
424B5
6rns21os5bj13h9s2
29 Jan 20
Prospectus supplement for primary offering
4:24pm
8-K
ihu9reb
27 Jan 20
Denali Therapeutics Announces Proposed Offering of Common Stock
5:13pm
424B5
iqgri0z57wfm9qyg
27 Jan 20
Prospectus supplement for primary offering
5:12pm
SC 13G/A
eb9quedqjkqz
16 Jan 20
Denali Therapeutics Inc.
10:41am
8-K
oi3yn4l
14 Jan 20
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results from Its LRRK2 Program for Parkinson’s Disease
9:04am
4
rmq5d eusn9r2
23 Dec 19
Denali Therapeutics / Carole Ho ownership change
7:35pm